|
Name |
Cytochalasin Z7
|
Molecular Formula | C28H35NO5 | |
IUPAC Name* |
(1S,4E,6S,7R,8S,10E,12S,13S,15S,16S,17S)-17-benzyl-7,13-dihydroxy-6,8,15-trimethyl-14-methylidene-2-oxa-18-azatricyclo[10.7.0.01,16]nonadeca-4,10-diene-3,19-dione
|
|
SMILES |
C[C@H]1C/C=C/[C@H]2[C@@H](C(=C)[C@H]([C@@H]3[C@]2(C(=O)N[C@H]3CC4=CC=CC=C4)OC(=O)/C=C/[C@@H]([C@@H]1O)C)C)O
|
|
InChI |
InChI=1S/C28H35NO5/c1-16-9-8-12-21-26(32)19(4)18(3)24-22(15-20-10-6-5-7-11-20)29-27(33)28(21,24)34-23(30)14-13-17(2)25(16)31/h5-8,10-14,16-18,21-22,24-26,31-32H,4,9,15H2,1-3H3,(H,29,33)/b12-8+,14-13+/t16-,17-,18+,21-,22-,24-,25+,26+,28+/m0/s1
|
|
InChIKey |
OZDYYVVFUQMENY-TZMRIDSPSA-N
|
|
Synonyms |
Cytochalasin Z7; CHEMBL497529; (1S,4E,6S,7R,8S,10E,12S,13S,15S,16S,17S)-17-Benzyl-7,13-dihydroxy-6,8,15-trimethyl-14-methylidene-2-oxa-18-azatricyclo[10.7.0.01,16]nonadeca-4,10-diene-3,19-dione; 896133-06-5
|
|
CAS | NA | |
PubChem CID | 11705387 | |
ChEMBL ID | CHEMBL497529 |
Chemical Classification: |
|
|
---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
---|---|---|---|---|---|---|---|---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
Molecular Weight: | 465.6 | ALogp: | 2.9 |
HBD: | 3 | HBA: | 5 |
Rotatable Bonds: | 2 | Lipinski's rule of five: | Accepted |
Polar Surface Area: | 95.9 | Aromatic Rings: | 4 |
Heavy Atoms: | 34 | QED Weighted: | 0.457 |
Caco-2 Permeability: | -5.235 | MDCK Permeability: | 0.00009490 |
Pgp-inhibitor: | 0 | Pgp-substrate: | 0.023 |
Human Intestinal Absorption (HIA): | 0.273 | 20% Bioavailability (F20%): | 0.011 |
30% Bioavailability (F30%): | 0.035 |
Blood-Brain-Barrier Penetration (BBB): | 0.838 | Plasma Protein Binding (PPB): | 95.47% |
Volume Distribution (VD): | 1.262 | Fu: | 5.48% |
CYP1A2-inhibitor: | 0.065 | CYP1A2-substrate: | 0.1 |
CYP2C19-inhibitor: | 0.104 | CYP2C19-substrate: | 0.476 |
CYP2C9-inhibitor: | 0.074 | CYP2C9-substrate: | 0.047 |
CYP2D6-inhibitor: | 0.01 | CYP2D6-substrate: | 0.101 |
CYP3A4-inhibitor: | 0.86 | CYP3A4-substrate: | 0.315 |
Clearance (CL): | 7.794 | Half-life (T1/2): | 0.019 |
hERG Blockers: | 0.171 | Human Hepatotoxicity (H-HT): | 0.333 |
Drug-inuced Liver Injury (DILI): | 0.157 | AMES Toxicity: | 0.02 |
Rat Oral Acute Toxicity: | 0.947 | Maximum Recommended Daily Dose: | 0.952 |
Skin Sensitization: | 0.203 | Carcinogencity: | 0.689 |
Eye Corrosion: | 0.003 | Eye Irritation: | 0.012 |
Respiratory Toxicity: | 0.983 |
Similar NPs | Similar Drugs | ||||||
---|---|---|---|---|---|---|---|
NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
ENC002161 | 0.757 | D0SP3D | 0.247 | ||||
ENC004369 | 0.729 | D09NNH | 0.247 | ||||
ENC006133 | 0.634 | D0V3ZA | 0.247 | ||||
ENC003955 | 0.634 | D01TSI | 0.240 | ||||
ENC005761 | 0.609 | D06CWH | 0.237 | ||||
ENC003300 | 0.595 | D0I0DL | 0.235 | ||||
ENC004243 | 0.595 | D08UMH | 0.233 | ||||
ENC003685 | 0.591 | D0E4DW | 0.231 | ||||
ENC004120 | 0.590 | D0D7KC | 0.231 | ||||
ENC002419 | 0.582 | D0U5RT | 0.230 |